Ayala Pharmaceuticals Debt/Equity
What is the Debt/Equity of Ayala Pharmaceuticals?
The Debt/Equity of Ayala Pharmaceuticals Inc. is 1.07
What is the definition of Debt/Equity?
Debt to equity ratio is a financial ratio indicating the relative proportion of shareholders’ equity and debt used to finance a company’s assets.
lfy (last fiscal year)
The debt to equity ratio is generally calculated by dividing debt by equity. The D/E ratio is also known as risk, gearing or leverage. The two components are often taken from the firm's balance sheet or statement of financial position (so-called book value), but the ratio may also be calculated using market values for both, if the company's debt and equity are publicly traded, or using a combination of book value for debt and market value for equity financially. Preferred stock can be considered part of debt or equity. Attributing preferred shares to one or the other is partially a subjective decision but will also take into account the specific features of the preferred shares. When used to calculate a company's financial leverage, the debt usually includes only the long-term debt.
Debt/Equity of companies in the Health Care sector on NASDAQ compared to Ayala Pharmaceuticals
What does Ayala Pharmaceuticals do?
advaxis (nasdaq: adxs) is a late -stage biotechnology company developing multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer. the advaxis technology, using bioengineered live attenuated bacteria, listeria monocytogenes (lm), actively suppresses key components in the tumor microenvironment that contribute to the tumors growth and protection from immunologic attack.
Companies with debt/equity similar to Ayala Pharmaceuticals
- N R Agarwal Industries has Debt/Equity of 1.07
- Montrose Environmental has Debt/Equity of 1.07
- Smruthi Organics has Debt/Equity of 1.07
- Locality Planning has Debt/Equity of 1.07
- GR Properties has Debt/Equity of 1.07
- Genocea Biosciences has Debt/Equity of 1.07
- Ayala Pharmaceuticals has Debt/Equity of 1.07
- Finsbury Food Plc has Debt/Equity of 1.07
- Wockhardt has Debt/Equity of 1.07
- Compagnie Financière Richemont SA has Debt/Equity of 1.07
- Tsuruha has Debt/Equity of 1.07
- RF Industries has Debt/Equity of 1.07
- Orbit Garant Drilling has Debt/Equity of 1.07